Description of a novel MHC class II restricted allogeneic TCR T cell therapy for acute myeloid leukaemia
Acute myeloid leukaemia (AML) is an aggressive blood cancer that can be treated with allogeneic haematopoietic stem cell transplantation (allo-HSCT). Although allo-HSCT reduces the chance of relapse because of the Graft-versus-leukaemia (GvL) effect, it is also associated with the Graft-versus-Host...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
2023
|